Inspire Medical Systems, Inc.
INSP
$42.44
$0.160.38%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.94% | 13.60% | 16.81% | 22.05% | 27.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.94% | 13.60% | 16.81% | 22.05% | 27.11% |
| Cost of Revenue | 0.97% | 8.33% | 15.72% | 24.97% | 27.10% |
| Gross Profit | 10.39% | 14.55% | 17.01% | 21.53% | 27.12% |
| SG&A Expenses | 15.37% | 17.94% | 17.96% | 16.29% | 15.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.32% | 12.30% | 13.99% | 13.88% | 13.40% |
| Operating Income | 3.02% | 41.21% | 172.13% | 389.66% | 238.41% |
| Income Before Tax | -11.16% | 12.39% | 40.36% | 589.12% | 612.11% |
| Income Tax Expenses | -1,330.56% | -1,712.56% | 86.03% | 124.92% | 224.87% |
| Earnings from Continuing Operations | 97.18% | 171.77% | 34.82% | 783.73% | 522.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.18% | 171.77% | 34.82% | 783.73% | 522.69% |
| EBIT | 3.02% | 41.21% | 172.13% | 389.66% | 238.41% |
| EBITDA | 14.98% | 52.26% | 168.37% | 598.11% | 278.03% |
| EPS Basic | 102.92% | 180.17% | 34.90% | 785.52% | 514.98% |
| Normalized Basic EPS | -3.04% | 22.43% | 62.67% | 636.41% | 602.47% |
| EPS Diluted | 107.51% | 189.20% | 36.16% | 852.96% | 493.41% |
| Normalized Diluted EPS | -1.23% | 25.21% | 63.97% | 671.93% | 576.78% |
| Average Basic Shares Outstanding | -2.23% | -1.32% | -0.31% | 0.58% | 1.20% |
| Average Diluted Shares Outstanding | -4.16% | -2.28% | -0.60% | 1.32% | 3.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |